Literature DB >> 23354369

A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria.

Kayode Olusegun Ajenifuja1, Julia C Gage, Akinfolarin C Adepiti, Nicolas Wentzensen, Claire Eklund, Mary Reilly, Martha Hutchinson, Robert D Burk, Mark Schiffman.   

Abstract

OBJECTIVE: Cervical cancer is the most common gynecological cancer in developing countries. Visual inspection with acetic acid (VIA) was introduced to screen for cervical premalignant lesions in developing countries owing to the inability of many countries to implement high-quality cytologic services. We sought to compare VIA performance among different health workers in Nigeria.
METHODS: In a population-based project, 7 health workers who had been screening women with VIA for approximately 2 years at local government health centers in rural Nigeria were retrained in a 2-week program using the International Agency for Research on Cancer training manual. Women from a rural village who had never had cervical cancer screening were recruited into the study. Each woman had cervical cancer screening by VIA, liquid-based cytologic test, and oncogenic human papillomavirus (HPV) DNA test.
RESULTS: Despite similar participant characteristics, across all age groups, providers had wide ranges of VIA results; 0% to 21% suspect cancer and 0% to 25% were VIA positive. Visual inspection with acetic acid was insensitive compared to a combination of cytologic and HPV tests.
CONCLUSION: In our study, VIA was not reproducible, nor was it sensitive compared to cytologic and HPV tests.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354369      PMCID: PMC3580031          DOI: 10.1097/IGC.0b013e318280f395

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  21 in total

1.  Analysis of the histopathological pattern of carcinoma of the cervix in Ilorin, Nigeria.

Authors:  K A Adeniji
Journal:  Niger J Med       Date:  2001 Oct-Dec

2.  Cervical cancer screening by visual inspection with acetic acid--interobserver variability between nurse and physician.

Authors:  Bhavana Sherigar; Anita Dalal; Geeta Durdi; Yeshita Pujar; Hema Dhumale
Journal:  Asian Pac J Cancer Prev       Date:  2010

3.  Cervical cancer--a neglected health tragedy.

Authors:  U Onwudiegwu; A Bako; A Oyewumi
Journal:  J Obstet Gynaecol       Date:  1999-01       Impact factor: 1.246

4.  Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995.

Authors:  E Chokunonga; L M Levy; M T Bassett; B G Mauchaza; D B Thomas; D M Parkin
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

Review 5.  Cancer of the uterine cervix.

Authors:  S A Cannistra; J M Niloff
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

6.  Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico.

Authors:  E C Lazcano-Ponce; S Moss; P Alonso de Ruíz; J Salmerón Castro; M Hernández Avila
Journal:  Arch Med Res       Date:  1999 May-Jun       Impact factor: 2.235

7.  Evaluation of alternative methods of cervical cancer screening for resource-poor settings.

Authors:  L Denny; L Kuhn; A Pollack; H Wainwright; T C Wright
Journal:  Cancer       Date:  2000-08-15       Impact factor: 6.860

8.  Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.

Authors:  J Belinson; Y L Qiao; R Pretorius; W H Zhang; P Elson; L Li; Q J Pan; C Fischer; A Lorincz; D Zahniser
Journal:  Gynecol Oncol       Date:  2001-11       Impact factor: 5.482

9.  Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker.

Authors:  N Bhatla; A Mukhopadhyay; S Joshi; A Kumar; A Kriplani; R M Pandey; K Verma
Journal:  Indian J Cancer       Date:  2004 Jan-Mar       Impact factor: 1.224

10.  Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India.

Authors:  R Sankaranarayanan; R Rajkumar; P O Esmy; J M Fayette; S Shanthakumary; L Frappart; S Thara; J Cherian
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

View more
  22 in total

Review 1.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

2.  Performance of visual Inspection With Acetic Acid for Cervical Cancer Screening as Compared to Human papillomavirus Deoxyribonucleic acid Testing Among Women With HIV in Ethiopia: A Comparative Cross-sectional Study.

Authors:  Agajie Likie Bogale; Tilahun Teklehaymanot; Getnet Mitike Kassie; Girmay Medhin; Jemal Haidar Ali; Nega Berhe Belay
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

Review 3.  Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.

Authors:  Joël Fokom-Domgue; Christophe Combescure; Victoire Fokom-Defo; Pierre Marie Tebeu; Pierre Vassilakos; André Pascal Kengne; Patrick Petignat
Journal:  BMJ       Date:  2015-07-03

4.  Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru.

Authors:  Maribel Almonte; Catterina Ferreccio; Silvana Luciani; Miguel Gonzales; Jose M Delgado; Carlos Santos; Manuel Alvarez; Jack Cuzick; Peter Sasieni
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

5.  Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.

Authors:  Betania Allen-Leigh; Patricia Uribe-Zúñiga; Leith León-Maldonado; Brandon J Brown; Attila Lörincz; Jorge Salmeron; Eduardo Lazcano-Ponce
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

6.  Implementation of HPV-based screening in Burkina Faso: lessons learned from the PARACAO hybrid-effectiveness study.

Authors:  Keitly Mensah; Charles Kaboré; Salifou Zeba; Magali Bouchon; Véronique Duchesne; Dolorès Pourette; Pierre DeBeaudrap; Alexandre Dumont
Journal:  BMC Womens Health       Date:  2021-06-23       Impact factor: 2.809

7.  Evaluation of stationary colposcope and the Gynocular, by the Swede score systematic colposcopic system in VIA positive women: a crossover randomized trial.

Authors:  Ashrafun Nessa; Charlotte Wistrand; Shirin Akter Begum; Marcus Thuresson; Isaac Shemer; Malin Thorsell; Elisabeth Andrea Wikström Shemer
Journal:  Int J Gynecol Cancer       Date:  2014-02       Impact factor: 3.437

Review 8.  Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective.

Authors:  Sarah Finocchario-Kessler; Catherine Wexler; May Maloba; Natabhona Mabachi; Florence Ndikum-Moffor; Elizabeth Bukusi
Journal:  BMC Womens Health       Date:  2016-06-04       Impact factor: 2.809

9.  Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.

Authors:  Tara J Wu; Karen Smith-McCune; Miriam Reuschenbach; Magnus von Knebel Doeberitz; May Maloba; Megan J Huchko
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692

10.  Cervical cancer in Zimbabwe: a situation analysis.

Authors:  Oppah Kuguyo; Alice Matimba; Nomsa Tsikai; Thulani Magwali; Mugove Madziyire; Muchabayiwa Gidiri; Collet Dandara; Charles Nhachi
Journal:  Pan Afr Med J       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.